cbdMD (YCBD) Cash from Financing Activities (2016 - 2025)

cbdMD (YCBD) reported Cash from Financing Activities of $2.1 million for Q4 2025, up 45.58% sequentially from $1.4 million in Q3 2025.

cbdMD (YCBD) Cash from Financing Activities (2016 - 2025) Analysis & Trends

cbdMD (YCBD) has 10 years of Cash from Financing Activities data on file, last reported at $2.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities changed N/A year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (up 173.01% YoY), and the FY2025 full-year result was $1.4 million, up 11.39% from the prior year.
  • Cash from Financing Activities grew to $2.1 million in Q4 2025, from $1.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $13.8 million in Q3 2021 to a low of -$1.1 million in Q4 2022.
  • A 5-year average of $752267.8 and a median of -$619751.0 in 2021 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities slumped 142.35% in 2021 and jumped 144523500.0% in 2025, its largest moves.
  • Tracing YCBD's Cash from Financing Activities over 5 years: stood at -$1.0 million in 2021, then dropped by 10.92% to -$1.1 million in 2022, then jumped by 99.78% to -$2501.0 in 2023, then soared by 100.04% to $1.0 in 2024, then soared by 210395600.0% to $2.1 million in 2025.
  • Business Quant data shows YCBD's Cash from Financing Activities at $2.1 million in Q4 2025, $1.4 million in Q3 2025, and $1.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 cbdMD 438,678.80 -2.95 Mn 3.00 Mn 2.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.10 Mn
Dec 31, 2025 2.10 Mn
Sep 30, 2025 1.45 Mn
Sep 30, 2025 1.45 Mn
Sep 30, 2024 1.00
Sep 30, 2024 1.00
Mar 31, 2024 1.30 Mn
Mar 31, 2024 1.30 Mn
Dec 31, 2023 -2,501.00
Dec 31, 2023 -2,501.00
Sep 30, 2023 -665,198.00
Sep 30, 2023 -665,198.00
Jun 30, 2023 1.47 Mn
Jun 30, 2023 1.47 Mn
Mar 31, 2023 -1.00 Mn
Mar 31, 2023 -1.00 Mn
Dec 31, 2022 -1.13 Mn
Dec 31, 2022 -1.13 Mn
Sep 30, 2022 -1.00 Mn
Sep 30, 2022 -1.00 Mn